Home › Mild Cognitive Impairment › Texas › Austin
Mild Cognitive Impairment clinical trials in Austin, TX
5 studies for Mild Cognitive Impairment are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline
RecruitingHealthy volunteers welcome
- Health Discovery Building, Austin
Enhancing Attention in Elderly Using a Brain-Computer-Interface
RecruitingHealthy volunteers welcome
- The University of Texas at Austin, Austin
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
RecruitingPhase 2
- Community Clinical Research, Austin
Cognitive Screening Made Easy for PCPs - Administrative Supplement
RecruitingHealthy volunteers welcome
- Family Wellness Clinic, Austin
- University of Texas Health Austin Primary Care Clinic, Austin
Paper-Based and Smartphone-Based Memory Supports
Recruiting
- UT Health Austin Comprehensive Memory Center, Austin
About Mild Cognitive Impairment
In mild cognitive impairment (MCI), you have more memory and thinking problems than others your age, but they don't interfere with your everyday life.
More about Mild Cognitive Impairment on MedlinePlus
Mild Cognitive Impairment trials in other cities
- New York City, NY23 studies
- Boston, MA21 studies
- Chicago, IL17 studies
- Baltimore, MD16 studies
- Los Angeles, CA12 studies
- Miami, FL11 studies
- Philadelphia, PA11 studies
- Birmingham, AL11 studies
- San Francisco, CA10 studies
- Houston, TX10 studies
- Durham, NC9 studies
- Washington, DC9 studies
Other studies in Austin
- Non-Small Cell Lung Cancer30 studies
- Cancer (all types)21 studies
- Obesity20 studies
- Colorectal Cancer19 studies
- Metastatic Cancer19 studies
- Heart Failure18 studies
- Overweight18 studies
- Breast Cancer18 studies
- Ovarian Cancer17 studies
- Endometrial Cancer16 studies
- Prostate Cancer15 studies
- Depression14 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.